Manila, Philippines - The former dean of the Philippine College of Physicians issued a warning on Thursday evening stating that the Philippines is in the midst of an "e-cigarette epidemic" affecting children as young as 13 years old.
We are now entering a surge in popularity of electronic cigarettes. We know this surge is real because 40% of Filipino children aged 13 to 15 are already using e-cigarettes," said Maricar Limpin in an interview with The Chief on One News. She lamented that there are even more teenagers using e-cigarettes compared to older adults, but did not cite any specific figures.
Dr. Lin Bin, a pulmonologist and anti-tobacco advocate, stated that popularity of e-cigarettes begins in early life. He added that flavor restrictions have been lifted in e-cigarette legislation, which previously only allowed tobacco and menthol flavors.
Limpin spoke in a mix of Filipino and English saying, "They say that as long as the taste is not appealing to children, but there are so many that are appealing to children, so this is very difficult.
She also warned that research suggests that people who vape are "twice as likely" to smoke, four times as likely to drink alcohol, and five times as likely to use illegal drugs.
Limpin stated that they will continue to oppose the vape bill that went into effect on Monday and will raise questions to the Supreme Court.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
